Filing Flows

Filing Flows › Companies › Genpact › Cash flow

Genpact cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$76.4M in Q3 2026 · $357M over twelve months

Operating cash flow$93.1M
Capital spending−$16.7M
Free cash flow+$76.4M
Cash / net income0.6×
Cash conversion cycle98 days

Analysis

In Q3 2026, Genpact generated $93.1M of operating cash flow and spent $16.7M on capital projects, leaving free cash flow of $76.4M. That is $216M less than in Q3 2025 ($292M).

Over the twelve months to Sep 30, 2026, operating cash flow was $429M; the largest uses were net borrowing (+) / repaid (−) ($386M), dividends ($124M), capital spending ($72.2M); besides operations, cash came from other financing ($17.0M), shares issued ($10.4M); the cash balance fell by $242M.

Operating cash flow was $93.1M against net income of $152M — 0.6× profit, less cash than reported earnings, worth checking against working capital. The largest differences: receivables −$231M, accrued liabilities +$134M, stock-based pay +$31.2M.

Its cash conversion cycle was 98 days (receivables 100 + inventory 0 − payables 2).

Free cash flow

Genpact: free cash flow by quarterGenpact: free cash flow by quarter$184MQ4 2024$18.5MQ1 2025$155MQ2 2025$292MQ3 2025$269MQ4 2025−$47.5MQ1 2026$58.5MQ2 2026$76.4MQ3 2026
Operating cash flow less capital spending.
Genpact: operating cash flow against capital spendingGenpact: operating cash flow against capital spendingOperating cash flowCapital spending$203M$19.7MQ4 2024$40.4M$22.0MQ1 2025$177M$22.2MQ2 2025$308M$16.3MQ3 2025$287M$17.7MQ4 2025−$23.5M$23.9MQ1 2026$72.4M$13.9MQ2 2026$93.1M$16.7MQ3 2026
Latest (Q3 2026): Operating cash flow $93.1M, Capital spending $16.7M.

Capital allocation, year by year

Genpact: where the cash came from (up) and went (down), by fiscal yearGenpact: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksDividendsFY2021: Operating cash flow $694MFY2021: Net borrowing $52.1MFY2021: Shares issued $23.2MFY2021: Asset sales $6.4MFY2021: Capital spending −$53.3MFY2021: Acquisitions −$72.0MFY2021: Buybacks −$298MFY2021: Dividends −$80.5M$776MFY2021FY2022: Operating cash flow $444MFY2022: Net borrowing −$243MFY2022: Shares issued $14.7MFY2022: Asset sales $17.8MFY2022: Capital spending −$50.6MFY2022: Acquisitions −$33KFY2022: Buybacks −$214MFY2022: Dividends −$91.8M$476MFY2022FY2023: Operating cash flow $491MFY2023: Net borrowing −$173MFY2023: Shares issued $27.8MFY2023: Asset sales −$19.5MFY2023: Capital spending −$55.4MFY2023: Acquisitions −$682KFY2023: Buybacks −$225MFY2023: Dividends −$100M$519MFY2023FY2024: Operating cash flow $615MFY2024: Net borrowing −$71.4MFY2024: Shares issued $7.2MFY2024: Asset sales $2.6MFY2024: Capital spending −$82.8MFY2024: Buybacks −$253MFY2024: Dividends −$108M$625MFY2024FY2025: Operating cash flow $813MFY2025: Net borrowing $314MFY2025: Shares issued $8.1MFY2025: Asset sales $59KFY2025: Capital spending −$78.2MFY2025: Acquisitions −$80.4MFY2025: Dividends −$118M$1.1BFY2025
Over these 5 years operating cash flow totalled $3.1B; the largest uses were buybacks ($990M) and dividends ($499M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$499M
Debt$1.2B
Net debt$675M
Due within a year$26.2M

Genpact funds itself: free cash flow was $357M over the last twelve months, and $499M of cash and investments stands against $1.2B of debt ($26.2M due within a year, 19.0× covered by cash).

Where the cash came from and went

Genpact: sources (+) and uses (−) of cash, Q3 2026Genpact: sources (+) and uses (−) of cash, Q3 2026Operating cash flow$93.1MDividends−$31.4MOther financing−$31.0MCash drawn (+) / kept (−)$18.3MExchange rates−$16.8MCapital spending−$16.7MNet borrowing (+) / repaid (−)−$8.9MOther investing−$8.8MShares issued$2.1MAsset & business sales$675KTaxes on employees’ shares−$594K
Genpact: sources (+) and uses (−) of cash, TTM to Q3 2026Genpact: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow$429MNet borrowing (+) / repaid (−)−$386MCash drawn (+) / kept (−)$242MDividends−$124MCapital spending−$72.2MExchange rates−$67.2MOther investing−$29.1MTaxes on employees’ shares−$24.2MOther financing$17.0MShares issued$10.4MAsset & business sales$4.4M

From profit to cash

Genpact: net income to operating cash flow, Q3 2026Genpact: net income to operating cash flow, Q3 2026Net income$152MDepreciation & amortization$21.3MStock-based pay$31.2MDeferred taxes$840KOther non-cash$341KReceivables−$231MPayables$8.6MAccrued liabilities$134MIncome taxes payable$40KOperating cash flow$93.1M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 2026100—298
Q2 202690—288
Q1 202687—384
Q4 202588—384
Q3 202591—486
Q2 202589—585
Q1 202589—484
Q4 202489—386

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsDividendsNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$93.1M−$16.7M—−$31.4M−$8.9M$2.1M$18.3M$76.4M
Q2 2026$72.4M−$13.9M—−$31.6M−$358M$2.3M$60.7M$58.5M
Q1 2026−$23.5M−$23.9M—−$31.8M−$9.0M$2.8M$276M−$47.5M
Q4 2025$287M−$17.7M—−$29.0M$340M$3.2M−$113M$269M
Q3 2025$308M−$16.3M$237K−$29.3M−$93.7M$5.0M−$77.5M$292M
Q2 2025$177M−$22.2M—−$29.6M$76.2M$2.4M−$102M$155M
Q1 2025$40.4M−$22.0M—−$29.8M−$9.0M$6.9M$86.6M$18.5M
Q4 2024$203M−$19.7M—−$26.7M−$410M$5.0M$374M$184M

Genpact: income statement and cash flow

Genpact, Q3 2026: revenue $1.4B (+7% year over year), operating margin 15.2%. The chart follows the revenue to costs, profit and cash.

Genpact: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.